Epilepsy is a complex neurological disorder affecting millions worldwide, with a substantial number of patients facing drug-resistant epilepsy (DRE). The historical journey from superstition to scientific understanding has greatly influenced the contemporary landscape of epilepsy research and treatment. Dating back to ancient times, epilepsy was often shrouded in misconceptions and attributed to supernatural causes. It was not until the late 19th and early 20th centuries that scientific advancements, such as the discovery of the electrical nature of brain activity, laid the foundation for a more accurate understanding of epilepsy. This newfound knowledge spurred the development of early treatments, including the introduction of antiseizure medications in the mid-20th century. While traditional antiseizure medications (ASMs) have been the cornerstone of epilepsy management for decades, a significant proportion of patients continue to experience seizures despite treatment. Ongoing research and technological advancements are paving the way for more targeted and personalized treatment approaches, offering hope for individuals with DRE.
This program has received an unrestricted educational grant or in-kind support from Paladin Pharma Inc.